Sarepta Therapeutics Inc. (SRPT) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Sarepta Therapeutics Inc., updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$19.32
+2.28% today
Market cap
$2.0B
Overall quality
—
Kronos AI 30-day
−10.4%
0 of 8 simulated paths end higher
Sarepta Therapeutics Inc. (SRPT) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $2.0B. It trades at $19.32, up 2.28% today. 16 analysts' average target of $21.53 implies +11.4% from today's price. Kronos AI's 30-day forecast is −10.4% (0 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $21.53 |
| Low – high | $5.00 – $38.00 |
| Analysts | 16 |
| Upside to average | +11.4% |
Kronos AI 30-day forecast
| Expected close | $16.92 (−10.4%) |
| Likely range | −13.7% … −5.7% |
| As of | 2026-10-27 |
0 of 8 simulated paths end higher.
Quality scores
Not scored: the financial data for this listing is incomplete.
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.